• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL OBT_CONCL_4.0,175_CW_STORZ; RIGID ENDOSCOPE OBTURATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL OBT_CONCL_4.0,175_CW_STORZ; RIGID ENDOSCOPE OBTURATOR Back to Search Results
Model Number 242585
Device Problem Material Deformation (2976)
Patient Problem Tissue Damage (2104)
Event Date 06/18/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Investigation summary: the complaint device is not being returned, it was retained by the customer, therefore unavailable for a physical evaluation.With the information provided, and without the complaint device to evaluate, we cannot determine a root cause for the reported failure.Further, no lot numbers were supplied which precludes conducting a dhr review or a lot specific search in the complaints handling system.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.
 
Event Description
It was reported by the affiliate in (b)(6) that during a knee arthroscopy procedure, it was observed that the obt_concl_4.0,175_cw_storz was too sharp.There was no delay the surgery.Another like device was used to complete the surgery successfully.There was damage to patient's cartilage.There were no fragments generated and there were no patient consequences.No additional information was provided.
 
Manufacturer Narrative
This report is being submitted in pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by mitek or its employees that the report constitutes an admission that the device, mitek, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Additional narrative: the complaint device is not being returned, it was retained by the customer, therefore unavailable for a physical evaluation.With the information provided, and without the complaint device to evaluate, we cannot determine a root cause for the reported failure.Further, no lot numbers were supplied which precludes conducting a dhr review or a lot specific search in the complaints handling system.At this point in time, no corrective action is required, and no further action is warranted.However, depuy synthes mitek will continue to track any related complaints within this device family as a means of monitoring the extent with which this complaint is observed in the field.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OBT_CONCL_4.0,175_CW_STORZ
Type of Device
RIGID ENDOSCOPE OBTURATOR
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin blanc 38
le locle CH-24 00
SZ  CH-2400
MDR Report Key10240600
MDR Text Key199894067
Report Number1221934-2020-01761
Device Sequence Number1
Product Code NBH
UDI-Device Identifier10886705028795
UDI-Public10886705028795
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 07/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number242585
Device Catalogue Number242585
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/01/2020
Initial Date FDA Received07/07/2020
Supplement Dates Manufacturer Received07/07/2020
Supplement Dates FDA Received07/10/2020
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-